尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Overseas Regulatory Announcement
2021-11-30
Overseas Regulatory Announcement
2021-11-25
Overseas Regulatory Announcement
2021-11-25
Overseas Regulatory Announcement
2021-11-23
Renewal of Continuing Connected Transactions and Related Party Transaction
2021-11-23
Overseas Regulatory Announcement
2021-11-18
Overseas Regulatory Announcement
2021-11-12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2021-11-01
Overseas Regulatory Announcement
2021-10-28
Proposed Adoption of Share Option Scheme and Grant Thereunder
2021-10-28
<
...
23
24
25
26
27
28
29
...
>